D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Huntington Ingalls Industries
HII
$11.3B
| $14.2M | 0.02% |
68,606
+46,469
| +210% | +$9.53M |
|
|
ENDP
877
DELISTED
Endo International plc
ENDP
| $14.2M | 0.02% |
1,764,691
-1,575,875
| -47% | -$14.8M |
|
878
GameStop
GME
$9.5B
| $14.1M | 0.02% |
5,556,972
+4,794,308
| +629% | +$14.9M |
|
879
CALL
Paycom
PAYC
$6.78B
| $14.1M | 0.02% |
74,600
+18,900
| +34% | +$3.07M |
|
880
Mercury Systems
MRCY
$6.2B
| $14.1M | 0.02% |
220,056
+57,316
| +35% | +$3.3M |
|
881
iRhythm Holdings
IRTC
$3.59B
| $14.1M | 0.02% |
187,552
+106,380
| +131% | +$9.09M |
|
882
Neurocrine Biosciences
NBIX
$17.7B
| $14M | 0.02% |
159,284
-51,239
| -24% | -$4.28M |
|
883
Designer Brands
DBI
$277M
| $14M | 0.02% |
631,459
+383,957
| +155% | +$10.1M |
|
|
QUOT
884
DELISTED
Quotient Technology Inc
QUOT
| $14M | 0.02% |
1,414,974
+230,584
| +19% | +$2.37M |
|
885
CALL
Lam Research
LRCX
$382B
| $13.9M | 0.02% |
776,000
-350,000
| -31% | -$5.84M |
|
886
PUT
Bausch Health
BHC
$1.65B
| $13.8M | 0.02% |
560,000
-1,010,000
| -64% | -$24.1M |
|
887
Sibanye-Stillwater
SBSW
$5.92B
| $13.8M | 0.02% |
3,337,459
| – | – |
|
888
Cimpress
CMPR
$2.37B
| $13.7M | 0.02% |
170,960
-134,006
| -44% | -$12.2M |
|
889
Jack Henry & Associates
JKHY
$10.7B
| $13.6M | 0.02% |
98,363
+30,990
| +46% | +$4.1M |
|
|
AGN
890
CALL
DELISTED
Allergan plc
AGN
| $13.6M | 0.02% |
93,100
-2,700
| -3% | -$391K |
|
891
Wingstop
WING
$3.68B
| $13.6M | 0.02% |
179,117
+130,617
| +269% | +$8.9M |
|
|
FOLD
892
DELISTED
Amicus Therapeutics
FOLD
| $13.6M | 0.02% |
1,000,626
+109,646
| +12% | +$1.34M |
|
893
CALL
LendingTree
TREE
$544M
| $13.6M | 0.02% |
+38,600
| New | +$11.7M |
|
894
Brixmor Property Group
BRX
$9.95B
| $13.6M | 0.02% |
738,421
-998,716
| -57% | -$17M |
|
895
Lincoln National
LNC
$7.91B
| $13.5M | 0.02% |
230,674
+177,581
| +334% | +$10.5M |
|
|
MXIM
896
DELISTED
Maxim Integrated Products
MXIM
| $13.5M | 0.02% |
254,549
-200,724
| -44% | -$10.8M |
|
|
ADSW
897
DELISTED
Advanced Disposal Services Inc
ADSW
| $13.5M | 0.02% |
482,477
+33,059
| +7% | +$860K |
|
898
Varex Imaging
VREX
$460M
| $13.5M | 0.02% |
398,610
-57,964
| -13% | -$1.75M |
|
899
PUT
Costco
COST
$415B
| $13.4M | 0.02% |
55,500
-328,300
| -86% | -$71.8M |
|
900
Tactile Systems Technology
TCMD
$620M
| $13.4M | 0.02% |
253,979
+229,514
| +938% | +$14.8M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.